9003-11-6 Purity
95%
If you have any other questions or need other size, please get a quote.
Specification
Chen, Xiang, et al. BMC biotechnology 16.1 (2016): 70.
Ethyl (R)-4-chloro-3-hydroxybutyrate ((R)-CHBE) is a high-value chiral synthon required for the manufacture of several pharmaceuticals, such as L-carnitine and some neuromodulators. The enzymatic asymmetric synthesis is the preferred mode of production, however the previously reported biocatalytic routes for (R)-CHBE have significant limitations, presenting a demand to develop an improved, more robust process.
A novel stereoselective carbonyl reductase (BgADH3) was discovered and utilized for the reduction of prochiral ethyl 4-chloro-3-oxobutanoate (COBE) to (R)-CHBE. BgADH3, which was isolated from Burkholderia gladioli, was shown to have high activity and enantioselectivity for this transformation.
Key Results
· To create an efficient production system, the BgADH3 enzyme was implemented in a whole-cell biocatalyst. Recombinant E. coli cells were engineered to co-express both BgADH3 and a glucose dehydrogenase, creating an integrated system for cofactor (NADPH) regeneration. This design eliminated the need for adding expensive external cofactors.
· The bioconversion was successfully scaled using a substrate fed-batch strategy in an aqueous/octanol biphasic system, which helped manage substrate and product inhibition. This optimized process achieved the complete conversion of 1200 mmol of COBE, producing (R)-CHBE with excellent enantiomeric excess (>99.9%). The process demonstrated high productivity, with a space-time yield of 4.47 mmol/L/h·g DCW-1.
Please kindly note that our products are for research use only.
Download